Forrest General Cancer Center

Hattiesburg, Mississippi 39401

0 studies enrolling now · 5 studies all time

What they study most

Advanced Multiple Myeloma, Diffuse Large B Cell Lymphoma, Esophageal Cancer, Head and Neck Cancer, Melanoma, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Solid Tumor, Adult

Studies at this site

• PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL — Completed
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma — Completed